Haven't used Clinoble Innovations yet?
Ask Trustburn

Questions about Clinoble Innovations

Based on 5 reviews, listing data and website checks · updated 6 days ago

What is Clinoble Innovations?

Clinoble Innovations is a Hyderabad, India-based medical technology company that develops clinical-grade medical screening platforms, including multi-cancer assays and portable diagnostics intended to detect disease before symptoms appear. The company builds instruments, assays, and software across chemistry, optics, machine learning, and regulatory functions, and is led by physicians and deep-tech researchers. It also provides EU MDR clinical evaluation services, such as Clinical Evaluation Reports (CERs), PMCF/PSUR documentation, deficiency responses, and preclinical evidence design.

What specific technologies and patents does Clinoble Innovations currently hold?

The company operates from Hyderabad, Telangana, India, and has ten live platforms currently available. Their portfolio includes deep-learning classifiers for heart sound analysis and patented technologies for tuberculosis detection. They hold multiple patent applications, including IND 202641088451 and IND 202641090786, which are pending at the Patent Office Chennai.

What are the core capabilities and services provided by Clinoble Innovations?

Clinoble Innovations offers a range of services including assay development, optics and sensing, machine learning model training, and regulatory engineering. They also provide clinical operations for multi-site studies and data infrastructure with HIPAA-grade pipelines. Their capabilities span methylation, cfDNA, and proteomic panels taken from bench to validated, deployable scale.

What is the primary mission and approach of Clinoble Innovations?

The company aims to detect diseases years before symptoms appear by analyzing circulating DNA, retinal microvasculature, and biomarkers. They build instruments, assays, and software that catch these signals at clinical grade and put them where care actually happens. Their mission focuses on early detection through engineered deep-tech R&D.

How does Clinoble Innovations ensure scientific rigor and regulatory compliance?

Clinoble Innovations emphasizes publishing peer-reviewed science before making press releases. They validate their machine learning models like devices, not demos, and work towards 510(k), De Novo, and CE-MDR pathways. Their architecture and evidence are planned around these regulatory pathways from day one.

What are some of the specific platforms available on Clinoble Innovations' website?

The company's platform services include Cardioscope Model 3, which uses deep-learning classifiers for heart sound analysis. They also offer Swinglight and Confounded TB Perturbation technologies for tuberculosis detection. These platforms are part of their broader medical screening offerings.

Who leads Clinoble Innovations and what is the team structure?

Clinoble Innovations is led by physicians and deep-tech researchers, with sole inventors like Dr. Jaideep Rao M. for their patent applications. The team works across six disciplines under one roof to remove seams between assay development, optics, machine learning, and regulatory engineering.

What are the key benefits of Clinoble Innovations' medical screening platforms?

Clinoble Innovations focuses on early detection of diseases, aiming to find conditions years before symptoms do. They validate their screening products at clinical grade and ensure peer review before any press release. Their approach prioritizes catching signals at clinical grade and deploying them where care happens.

How does Clinoble Innovations manage data infrastructure and clinical operations?

The company's data infrastructure includes HIPAA-grade pipelines moving petabytes of data. They run multi-site studies on their own telemetry, from first consent to database lock. This ensures robust and secure handling of clinical data for their screening platforms.

What is the current rating and review status of Clinoble Innovations on Trustburn?

Clinoble Innovations has a Trustburn rating of 4.4 out of 5 from 5 reviews. The company has ten live platforms and multiple patent applications in areas such as heart sound analysis. Their website lists these achievements prominently to showcase their capabilities.

Where can visitors find more information about Clinoble Innovations' offerings?

The company's website mentions that they are patent-backed with ten live platforms and multiple patent applications. They also highlight their focus on early detection and clinical-grade screening platforms. These details are available on their official website for potential clients.

Where is Clinoble Innovations located and which industries do they serve?

Clinoble Innovations is located in Hyderabad, Telangana, India, and serves the pharmaceuticals, medical devices, and biotechnology industries. They are known for their deep-tech R&D and clinical-grade screening platforms. The company's address is Hyderabad, Telangana, IN.

What are some of the key practices that Clinoble Innovations follows to maintain quality?

Clinoble Innovations is committed to publishing peer-reviewed papers and validating their models like devices. They also provide clinical evaluation services for EU MDR, including deficiency responses and preclinical evidence design. These practices ensure high standards in their medical screening platforms.

Based on reviews, listing data and the company's website. Verify anything important with the company directly.

Jessica Lin
Reviews 1

The vision here is absolutely thrilling! Building clinical-grade platforms that can detect disease years before symptoms appear is a game-changer. The fact that they are patent-backed and have live platforms already is fantastic. I love that they are focusing on deep-tech R&D with a clear mission to catch signals in circulating DNA and retinal microvasculature. It feels like we are on the brink of a major shift in how we handle preventative healthcare. The team’s dedication to publishing peer-reviewed papers before press releases shows a serious commitment to science. This is exactly the kind of innovation the medical field needs right now.

Michael Stone
Reviews 1

What stands out most about Clinoble is the vertical integration of chemistry, optics, machine learning, and regulatory engineering under one roof. The mission emphasizes catching signals years before symptoms, which aligns with the described capabilities in assay development and custom imaging stacks. It seems they have built a robust data infrastructure capable of moving petabytes of signal while maintaining provenance, which is crucial for clinical-grade devices. The fact that they peer-review their science before press releases suggests a commitment to evidence over marketing. While the EU MDR clinical evaluation services appear thorough, with physician-authored reports and structured deficiency responses, it is unclear if specific pricing tiers are available for different project scales. For someone considering their computational preclinical sciences or target validation services, the emphasis on power calculations and ARRIVE 2.0-compliant protocols indicates a serious scientific rigor. The team seems well-equipped to handle complex multi-site studies, but potential clients should verify if their specific diagnostic needs match the current pipeline of ten live platforms.

David Chen
Reviews 1

I see they have six disciplines under one roof, which is nice for integration. The platforms seem well-engineered with deep-learning classifiers. However, I noticed they are still working towards 510(k) and CE-MDR pathways, so the regulatory side might need closer watching until those approvals are fully secured for specific markets.

Elena Marsh
Reviews 1

What stands out about Clinoble Innovations is the way they have consolidated six distinct disciplines under one roof. From assay development to regulatory engineering, the information suggests a seamless workflow that removes the usual seams between different specialisms. For someone considering their platform services, knowing that optics, machine learning, and chemistry are handled in-house by the same team provides a strong sense of cohesion. It seems like a genuinely convenient setup for partners who want to avoid managing multiple vendors. The fact that they handle everything from telemetry to database locking implies a streamlined experience that could save significant time during multi-site studies.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="clinoble-com" data-lang="en"></div>
More widgets

About Clinoble Innovations

Clinoble Innovations is a Hyderabad, India-based medical technology company that develops clinical-grade medical screening platforms, including multi-cancer assays and portable diagnostics intended to detect disease before symptoms appear. The company builds instruments, assays, and software across chemistry, optics, machine learning, and regulatory functions, and is led by physicians and deep-tech researchers. It also provides EU MDR clinical evaluation services, such as Clinical Evaluation Reports (CERs), PMCF/PSUR documentation, deficiency responses, and preclinical evidence design. The website lists ten live platforms and multiple patent applications in areas such as heart sound analysis (Cardioscope Model 3) and tuberculosis screening (TB F.I.R.S.T. and Swinglight). Clinoble Innovations emphasizes peer-reviewed publication of its research and in-house regulatory expertise.

Address
Hyderabad, Telangana, IN